Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
76
days
Serum fibroblast growth factor-21 shows a stronger association with liver stiffness than fetuin-a in adults with type 2 diabetes mellitus undergoing non-invasive liver assessment: a cross-sectional study
Authors
Surender; Pushpender Khatana; Rajesh Rajput; Sunil Kumar Mishra; Mohammad Shafi Kuchay; SurjeetShow moreShow less
Affiliations
1. Medanta The Medicity; 2. Graphic Era UniversityShow moreShow less
28
days
Happy birthday Doctor Kußmaul!
Authors
Viktor JörgensShow moreShow less
Affiliations
1. Düsseldorf, GermanyShow moreShow less
58
days
Diabetic retinopathy and cognitive dysfunction: a systematic review and meta-analysis
Authors
Mei Wu; Fan Mei; Kaiyan Hu; Liyuan Feng; Zhe Wang; Qianqian Gao; Fei Chen; Li Zhao; Xiaohui Li; Bin MaShow moreShow less
Affiliations
1. Evidence-Based Medicine Centre, School of Basic Medical Sciences, School of Nursing, Lanzhou University, Lanzhou, China; 2. Lanzhou University second hospital, Lanzhou University, Lanzhou, China; 3. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, ChinaShow moreShow less
45
days
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)
Authors
Ilaria Dicembrini; Valentina Vitale; Claudia Cosentino; Barbara Cresci; Laura Pala; Maria Pieri; Dimitri Yannas; Matteo Vannucci; Elena Zago; Alessia Romani; Chiara Delli Poggi; Sara Liana Mariani; Daniele Scoccimarro; Carlotta Cocchetti; Matteo Monami; Edoardo MannucciShow moreShow less
Affiliations
1. Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy; 2. Diabetes Unit, Careggi Hospital, Florence, ItalyShow moreShow less
56
days
A systematic review of the prevalence, risk factors and screening tools for autonomic and diabetic peripheral neuropathy in children, adolescents and young adults with type 1 diabetes
Authors
Roberto Franceschi; Enza Mozzillo; Francesca Di Candia; Francesco Maria Rosanio; Letizia Leonardi; Alice Liguori; Francesca Micheli; Vittoria Cauvin; Adriana Franzese; Claudia Anita Piona; M. Loredana MarcovecchioShow moreShow less
Affiliations
1. Pediatric Diabetology Unit, Pediatric Department, S. Chiara General Hospital, Trento, Italy; 2. Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy; 3. Section of Pediatric Diabetes and Metabolism, Department of Surgery, Dentistry, Gynecology and Pediatrics, University and Azienda Ospedaliera, Universitaria Integrata of Verona, Verona, Italy; 4. Department of Paediatrics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UKShow moreShow less
78
days
Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
Authors
Archana Rai; Kim A. Connelly; Subodh Verma; C. David Mazer; Hwee Teoh; Ming-Yen Ng; Idan Roifman; Adrian Quan; Marina Pourafkari; Laura Jimenez-Juan; Venkat Ramanan; Yin Ge; Djeven P. Deva; Andrew T. YanShow moreShow less
Affiliations
1. Division of Cardiology, Department of Medical Imaging, St Michael’s Hospital, Toronto, Canada; 2. University of Toronto, Toronto, Canada; 3. Terrence Donnelly Heart Center, St Michael’s Hospital, Toronto, Canada; 4. Keenan Research Center, Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, Canada; 5. Division of Cardiac Surgery, St Michael’s Hospital, Toronto, Canada; 6. Department of Anesthesia, St Michael’s Hospital, Toronto, Canada; 7. Division of Endocrinology and Metabolism, St Michael’s Hospital, Toronto, Canada; 8. Department of Diagnostic Radiology, HKU-Shenzhen Hospital and Li Ka Shing Faculty of Medicine, The University of Hong Kong, Shenzhen and Hong Kong SAR, China; 9. Schulich Heart Center, Sunnybrook Health Sciences Center, Toronto, Canada; 10. Queen’s University, Kingston, CanadaShow moreShow less
FAQ
How long does ACTA DIABETOLOGICA take to review a manuscript?
As of 2026-11-19, CrushSCI has 11 complete review records for ACTA DIABETOLOGICA. The fastest paper went from submission to acceptance in 28 days (Happy birthday Doctor Kußmaul!, received 2021-12-09, accepted 2022-01-06); the slowest took 145 days. The average is 63.4 days and the median is 58 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
